In what it believes is an industry first, Roche Pharmaceuticals will offer its clinical development services to outside customers, particularly non-government organisations (NGOs), according to the drug giant's global head of clinical pharmacology development, Prof Graham McClelland.

Sydney-based drug developer Pharmaxis (ASX:PXS, Nasdaq:PXSL) has signed a European distribution agreement for its first product, Aridol.

Cochlear boss Chris Roberts has spent 30 years at Australia's leading device companies -- but that doesn't mean he has stopped learning, as Helen Schuller discovers.

A senior Biotechnology Australia bureaucrat has been grilled in a senate estimates committee by conservative Tasmanian independent senator Brian Harradine about the federal agency's attitude towards human embryonic stem cells.

The drug-discovery industry -- pharma and biotech alike -- will suffer a sea-change as the age of personalised medicine begins, said Steve Burrill at Monday's opening of the 2004 AusBiotech conference in Brisbane.